- Who can participate: Adults aged 18-65 with a diagnosis of the specific condition and meeting other inclusion criteria are eligible to participate.
- Study details: The study will be conducted at multiple sites, and participants will undergo regular assessments to monitor their health and the effects of the investigational medication.
The prescreener preview is complete. You may now close the preview.